Insel Gruppe AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.inselgruppe.ch
Utility of Real Time Continuous Glucose Monitoring in the Care of Gestational Diabetes Versus Standard Care in Pregnancy Outcomes
Not Applicable
Completed
- Conditions
- Gestational Diabetes
- Interventions
- Device: Dexcom G SystemDevice: Self monitoring blood glucose
- First Posted Date
- 2021-09-08
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 302
- Registration Number
- NCT05037526
- Locations
- 🇨🇭
University Hospital of Bern, Inselspital, Bern, Switzerland
Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era
Recruiting
- Conditions
- Thrombus of Left Ventricle
- First Posted Date
- 2021-08-31
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 550
- Registration Number
- NCT05028777
- Locations
- 🇨🇭
Department of Cardiology, University Hospital Bern, Bern, Switzerland
Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During Neurosurgery
Not Applicable
Completed
- Conditions
- AneurysmMeningiomaDural Arteriovenous FistulaMetastasisAVMGlioma
- Interventions
- Device: Laser speckle contrast imaging (LSCI)
- First Posted Date
- 2021-08-31
- Last Posted Date
- 2022-04-12
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 20
- Registration Number
- NCT05028400
- Locations
- 🇨🇭
Department of Neurosurgery, Bern, Switzerland
Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids
Phase 2
Recruiting
- Conditions
- Bladder CancerNon-muscle Invasive
- Interventions
- First Posted Date
- 2021-08-27
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Roland Seiler-Blarer
- Target Recruit Count
- 34
- Registration Number
- NCT05024734
- Locations
- 🇨🇭
Spitalzentrum Biel/Bienne, Biel, Switzerland
Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Intractable Cerebral Vasospasm
Not Applicable
Completed
- Conditions
- SAHVasospasmInhaled Nitric OxideCerebral Ischemia
- Interventions
- Drug: Inhaled nitric oxide
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2021-08-04
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 7
- Registration Number
- NCT04988932
- Locations
- 🇨🇭
Department of Neurosurgery, University Hospital Bern, Bern, Switzerland
Diagnostic Accuracy and Performance of 18F-PSMA-1007
Completed
- Conditions
- Prostate Cancer
- Interventions
- Diagnostic Test: [18F]PSMA-1007
- First Posted Date
- 2021-08-02
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 174
- Registration Number
- NCT04986280
- Locations
- 🇨🇭
Inselspital, Universitätsspital Bern, Bern, Switzerland
Prospective Cohort of HIV/HBV-coinfected Patients in Europe
- Conditions
- HIV InfectionsHepatitis BCoinfection
- First Posted Date
- 2021-08-02
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 1107
- Registration Number
- NCT04984772
Networks of Bacterium-Metabolite Interactions in the Small Intestine
Not Applicable
Terminated
- Conditions
- Microbial ColonizationDiet, Healthy
- Interventions
- Other: Test meal (high fat = Nutricia Calogen®, or high carbohydrate = Nutricia preOp®)
- First Posted Date
- 2021-07-27
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 120
- Registration Number
- NCT04978077
- Locations
- 🇨🇭
Inselspital, Bern, Switzerland
Low Carbohydrate Small Intestine Study
Not Applicable
Terminated
- Conditions
- Diet, Healthy
- Interventions
- Other: Diet modification
- First Posted Date
- 2021-07-26
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 13
- Registration Number
- NCT04976686
- Locations
- 🇨🇭
Inselspital, Bern, Switzerland
Evaluating the Safety of the SPECTRALIS CENTAURUS Device
Not Applicable
Recruiting
- Conditions
- Retinal Diseases
- Interventions
- Device: Selective retina therapy SPECTRALIS CENTAURUS device
- First Posted Date
- 2021-07-20
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 30
- Registration Number
- NCT04968756
- Locations
- 🇨🇭
University Hospital Inselspital, Bern, Switzerland
© Copyright 2025. All Rights Reserved by MedPath